Sarepta Therapeutics (SRPT) Insider Trading & Ownership

$141.91

-1.54 (-1.07%)

(As of 11:08 AM ET)

Current Insider Ownership Percentage: 7.70%
Number Of Insiders Buying (Last 12 Months): 3
Amount Of Insider Buying (Last 12 Months): $10.90 M
Number Of Insiders Selling (Last 12 Months): 7
Amount Of Insider Selling (Last 12 Months): $10.83 M

Get SRPT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Sarepta Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SRPT Insider Buying and Selling by Quarter

Ad Stansberry Research

Millionaire Investor Warns: “Brace for Apple Collapse”

Apple stock has quadrupled over the past five years. But now even Warren Buffett is pulling the plug. The Oracle of Omaha just sold HALF his stake – worth more than $75 billion in the iconic tech company.

To watch his fascinating interview which has taken Wall Street by storm, click here.

Sarepta Therapeutics Insider and Congressional Trades History

Transaction Type

Time Frame

Start Date

End Date

Export to Excel

Transaction Date	Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
8/16/2024	Michael Andrew Chambers	Director	Buy	37,038	$133.80	$4,955,684.40
6/25/2024	Ryan Edward Brown	EVP	Sell	38,957	$161.61	$6,295,840.77
6/24/2024	Bilal Arif	Insider	Sell	7,859	$163.08	$1,281,645.72
5/2/2024	Dallan Murray	Insider	Sell	3,635	$140.00	$508,900.00
3/11/2024	Kathryn Jean Boor	Director	Sell	761	$122.93	$93,549.73
3/8/2024	Hans Lennart Rudolf Wigzell	Director	Sell	15,000	$123.25	$1,848,750.00
Get Insider Trades Delivered To Your Inbox Enter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings.
3/5/2024	Stephen Mayo	Director	Sell	3,135	$122.96	$385,479.60
3/1/2024	Bilal Arif	Insider	Sell	2,000	$128.84	$257,680.00
3/1/2024	Ian Michael Estepan	CFO	Sell	1,200	$128.30	$153,960.00
11/3/2023	Douglas S Ingram	CEO	Buy	25,225	$79.36	$2,001,856.00
11/3/2023	Richard Barry	Director	Buy	50,000	$78.81	$3,940,500.00

(Data available from 1/1/2013 forward)

SRPT Insider Trading Activity - Frequently Asked Questions

Who is on Sarepta Therapeutics's Insider Roster?: The list of insiders at Sarepta Therapeutics includes Bilal Arif, Dallan Murray, Douglas S Ingram, Hans Lennart Rudolf Wigzell, Ian Michael Estepan, Kathryn Jean Boor, Louise Rodino-Klapac, Michael Andrew Chambers, Richard Barry, Ryan Edward Brown, and Stephen Mayo. Learn more on insiders at SRPT.
What percentage of Sarepta Therapeutics stock is owned by insiders?: 7.70% of Sarepta Therapeutics stock is owned by insiders. Learn more on SRPT's insider holdings.
Which Sarepta Therapeutics insiders have been buying company stock?: The following insiders have purchased SRPT shares in the last 24 months: Douglas S Ingram ($2,001,856.00), Michael Andrew Chambers ($15,712,170.58), and Richard Barry ($3,940,500.00).

How much insider buying is happening at Sarepta Therapeutics?: Insiders have purchased a total of 214,209 SRPT shares in the last 24 months for a total of $21,654,526.58 bought.
Which Sarepta Therapeutics insiders have been selling company stock?: The following insiders have sold SRPT shares in the last 24 months: Bilal Arif ($1,539,325.72), Dallan Murray ($508,900.00), Hans Lennart Rudolf Wigzell ($3,449,550.00), Ian Michael Estepan ($153,960.00), Kathryn Jean Boor ($93,549.73), Ryan Edward Brown ($6,295,840.77), and Stephen Mayo ($479,790.96).
How much insider selling is happening at Sarepta Therapeutics?: Insiders have sold a total of 88,405 Sarepta Therapeutics shares in the last 24 months for a total of $12,520,917.18 sold.